Num | GO | Overlap | Size | P Value | Adj. P Value |
1 |
REGULATION OF MULTICELLULAR ORGANISMAL DEVELOPMENT |
190 |
1672 |
8.477e-24 |
3.944e-20 |
2 |
IMMUNE SYSTEM PROCESS |
209 |
1984 |
4.285e-22 |
9.97e-19 |
3 |
REGULATION OF CELL PROLIFERATION |
170 |
1496 |
3.14e-21 |
4.871e-18 |
4 |
POSITIVE REGULATION OF RESPONSE TO STIMULUS |
200 |
1929 |
2.701e-20 |
3.142e-17 |
5 |
REGULATION OF CELL DIFFERENTIATION |
164 |
1492 |
5.044e-19 |
4.694e-16 |
6 |
MOVEMENT OF CELL OR SUBCELLULAR COMPONENT |
144 |
1275 |
9.559e-18 |
7.413e-15 |
7 |
REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION |
172 |
1656 |
1.797e-17 |
8.589e-15 |
8 |
LOCOMOTION |
131 |
1114 |
1.325e-17 |
8.589e-15 |
9 |
VASCULATURE DEVELOPMENT |
75 |
469 |
1.953e-17 |
8.589e-15 |
10 |
REGULATION OF ANATOMICAL STRUCTURE MORPHOGENESIS |
123 |
1021 |
2.215e-17 |
8.589e-15 |
11 |
NEGATIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS |
120 |
983 |
2.045e-17 |
8.589e-15 |
12 |
BIOLOGICAL ADHESION |
124 |
1032 |
1.991e-17 |
8.589e-15 |
13 |
REGULATION OF CELLULAR COMPONENT MOVEMENT |
102 |
771 |
2.793e-17 |
9.997e-15 |
14 |
BLOOD VESSEL MORPHOGENESIS |
64 |
364 |
4.12e-17 |
1.369e-14 |
15 |
POSITIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS |
151 |
1395 |
6.379e-17 |
1.979e-14 |
16 |
TISSUE DEVELOPMENT |
160 |
1518 |
7.689e-17 |
2.236e-14 |
17 |
CARDIOVASCULAR SYSTEM DEVELOPMENT |
102 |
788 |
1.262e-16 |
3.261e-14 |
18 |
CIRCULATORY SYSTEM DEVELOPMENT |
102 |
788 |
1.262e-16 |
3.261e-14 |
19 |
POSITIVE REGULATION OF DEVELOPMENTAL PROCESS |
130 |
1142 |
2.472e-16 |
6.053e-14 |
20 |
REGULATION OF NEURON DIFFERENTIATION |
79 |
554 |
2.117e-15 |
4.925e-13 |
21 |
REGULATION OF CELL DEVELOPMENT |
103 |
836 |
2.541e-15 |
5.63e-13 |
22 |
IMMUNE SYSTEM DEVELOPMENT |
81 |
582 |
3.708e-15 |
7.843e-13 |
23 |
REGULATION OF NERVOUS SYSTEM DEVELOPMENT |
95 |
750 |
5.97e-15 |
1.208e-12 |
24 |
POSITIVE REGULATION OF CELL PROLIFERATION |
100 |
814 |
8.063e-15 |
1.563e-12 |
25 |
CELL ACTIVATION |
79 |
568 |
8.554e-15 |
1.592e-12 |
26 |
CELL MOTILITY |
101 |
835 |
1.602e-14 |
2.761e-12 |
27 |
LOCALIZATION OF CELL |
101 |
835 |
1.602e-14 |
2.761e-12 |
28 |
POSITIVE REGULATION OF CELL COMMUNICATION |
154 |
1532 |
1.96e-14 |
3.257e-12 |
29 |
ANGIOGENESIS |
52 |
293 |
2.616e-14 |
4.197e-12 |
30 |
REGULATION OF CELL ADHESION |
83 |
629 |
3.532e-14 |
5.478e-12 |
31 |
CELL CELL ADHESION |
81 |
608 |
4.309e-14 |
6.468e-12 |
32 |
POSITIVE REGULATION OF PROTEIN METABOLIC PROCESS |
150 |
1492 |
4.487e-14 |
6.524e-12 |
33 |
CELL DEVELOPMENT |
145 |
1426 |
5.164e-14 |
7.282e-12 |
34 |
NEUROGENESIS |
143 |
1402 |
6.215e-14 |
8.505e-12 |
35 |
POSITIVE REGULATION OF PHOSPHATE METABOLIC PROCESS |
114 |
1036 |
2.131e-13 |
2.68e-11 |
36 |
POSITIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS |
114 |
1036 |
2.131e-13 |
2.68e-11 |
37 |
REGULATION OF PHOSPHORUS METABOLIC PROCESS |
157 |
1618 |
2.057e-13 |
2.68e-11 |
38 |
SINGLE ORGANISM CELL ADHESION |
66 |
459 |
3.143e-13 |
3.848e-11 |
39 |
POSITIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION |
101 |
876 |
3.32e-13 |
3.961e-11 |
40 |
POSITIVE REGULATION OF CELL DIFFERENTIATION |
96 |
823 |
6.72e-13 |
7.817e-11 |
41 |
NEGATIVE REGULATION OF DEVELOPMENTAL PROCESS |
94 |
801 |
8.356e-13 |
9.483e-11 |
42 |
POSITIVE REGULATION OF GENE EXPRESSION |
163 |
1733 |
9.087e-13 |
1.007e-10 |
43 |
POSITIVE REGULATION OF CATALYTIC ACTIVITY |
147 |
1518 |
1.602e-12 |
1.733e-10 |
44 |
REGULATION OF IMMUNE SYSTEM PROCESS |
138 |
1403 |
2.758e-12 |
2.917e-10 |
45 |
POSITIVE REGULATION OF BIOSYNTHETIC PROCESS |
166 |
1805 |
3.5e-12 |
3.614e-10 |
46 |
POSITIVE REGULATION OF MOLECULAR FUNCTION |
165 |
1791 |
3.573e-12 |
3.614e-10 |
47 |
LEUKOCYTE DIFFERENTIATION |
48 |
292 |
4.739e-12 |
4.692e-10 |
48 |
ANATOMICAL STRUCTURE FORMATION INVOLVED IN MORPHOGENESIS |
104 |
957 |
5.692e-12 |
5.518e-10 |
49 |
LEUKOCYTE ACTIVATION |
59 |
414 |
8.513e-12 |
8.084e-10 |
50 |
REGULATION OF PROTEIN MODIFICATION PROCESS |
158 |
1710 |
8.92e-12 |
8.301e-10 |
51 |
LYMPHOCYTE ACTIVATION |
52 |
342 |
1.301e-11 |
1.187e-09 |
52 |
POSITIVE REGULATION OF IMMUNE SYSTEM PROCESS |
96 |
867 |
1.383e-11 |
1.238e-09 |
53 |
REGULATION OF NEURON PROJECTION DEVELOPMENT |
58 |
408 |
1.422e-11 |
1.248e-09 |
54 |
RESPONSE TO EXTERNAL STIMULUS |
164 |
1821 |
2.593e-11 |
2.235e-09 |
55 |
POSITIVE REGULATION OF PROTEIN MODIFICATION PROCESS |
115 |
1135 |
3.622e-11 |
3.064e-09 |
56 |
NEGATIVE REGULATION OF CELL PROLIFERATION |
77 |
643 |
4.103e-11 |
3.409e-09 |
57 |
REGULATION OF CELL DEATH |
139 |
1472 |
4.303e-11 |
3.513e-09 |
58 |
INTRACELLULAR SIGNAL TRANSDUCTION |
145 |
1572 |
8.379e-11 |
6.722e-09 |
59 |
NEGATIVE REGULATION OF RESPONSE TO STIMULUS |
130 |
1360 |
8.948e-11 |
7.056e-09 |
60 |
POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER |
104 |
1004 |
9.691e-11 |
7.515e-09 |
61 |
REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER |
159 |
1784 |
1.219e-10 |
9.301e-09 |
62 |
CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION |
65 |
513 |
1.347e-10 |
1.011e-08 |
63 |
REGULATION OF MAPK CASCADE |
77 |
660 |
1.433e-10 |
1.058e-08 |
64 |
CELLULAR RESPONSE TO ORGANIC SUBSTANCE |
163 |
1848 |
1.509e-10 |
1.097e-08 |
65 |
REGULATION OF KINASE ACTIVITY |
86 |
776 |
1.637e-10 |
1.172e-08 |
66 |
REGULATION OF HOMOTYPIC CELL CELL ADHESION |
46 |
307 |
3.269e-10 |
2.305e-08 |
67 |
LEUKOCYTE CELL CELL ADHESION |
41 |
255 |
3.447e-10 |
2.394e-08 |
68 |
REGULATION OF AXONOGENESIS |
32 |
168 |
3.905e-10 |
2.672e-08 |
69 |
RESPONSE TO WOUNDING |
68 |
563 |
4.069e-10 |
2.744e-08 |
70 |
POSITIVE REGULATION OF CELL ADHESION |
52 |
376 |
4.478e-10 |
2.976e-08 |
71 |
POSITIVE REGULATION OF MAPK CASCADE |
60 |
470 |
5.218e-10 |
3.419e-08 |
72 |
POSITIVE REGULATION OF CELL DEATH |
71 |
605 |
5.929e-10 |
3.831e-08 |
73 |
RESPONSE TO ABIOTIC STIMULUS |
103 |
1024 |
6.277e-10 |
3.972e-08 |
74 |
MESENCHYME DEVELOPMENT |
34 |
190 |
6.317e-10 |
3.972e-08 |
75 |
REGULATION OF CELL CELL ADHESION |
52 |
380 |
6.56e-10 |
4.07e-08 |
76 |
TISSUE MORPHOGENESIS |
65 |
533 |
6.721e-10 |
4.115e-08 |
77 |
REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION |
48 |
337 |
7.78e-10 |
4.702e-08 |
78 |
NEGATIVE REGULATION OF CELL DIFFERENTIATION |
71 |
609 |
7.91e-10 |
4.719e-08 |
79 |
HEART DEVELOPMENT |
59 |
466 |
1.004e-09 |
5.913e-08 |
80 |
REGULATION OF CELL MORPHOGENESIS |
66 |
552 |
1.129e-09 |
6.565e-08 |
81 |
CELLULAR RESPONSE TO OXYGEN CONTAINING COMPOUND |
85 |
799 |
1.57e-09 |
9.021e-08 |
82 |
REGULATION OF CELL ACTIVATION |
60 |
484 |
1.645e-09 |
9.221e-08 |
83 |
POSITIVE REGULATION OF CELL DEVELOPMENT |
59 |
472 |
1.642e-09 |
9.221e-08 |
84 |
REGULATION OF CELL PROJECTION ORGANIZATION |
66 |
558 |
1.762e-09 |
9.762e-08 |
85 |
REGULATION OF IMMUNE RESPONSE |
89 |
858 |
2.233e-09 |
1.222e-07 |
86 |
REGULATION OF CHEMOTAXIS |
32 |
180 |
2.377e-09 |
1.286e-07 |
87 |
MESENCHYMAL CELL DIFFERENTIATION |
27 |
134 |
2.522e-09 |
1.349e-07 |
88 |
NEGATIVE REGULATION OF CELL COMMUNICATION |
113 |
1192 |
2.8e-09 |
1.481e-07 |
89 |
POSITIVE REGULATION OF NEURON DIFFERENTIATION |
44 |
306 |
2.941e-09 |
1.538e-07 |
90 |
REGULATION OF EPITHELIAL CELL PROLIFERATION |
42 |
285 |
3.196e-09 |
1.652e-07 |
91 |
POSITIVE REGULATION OF HYDROLASE ACTIVITY |
92 |
905 |
3.256e-09 |
1.665e-07 |
92 |
REGULATION OF VASCULATURE DEVELOPMENT |
37 |
233 |
3.538e-09 |
1.789e-07 |
93 |
POSITIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT |
55 |
437 |
4.622e-09 |
2.312e-07 |
94 |
TAXIS |
57 |
464 |
5.899e-09 |
2.92e-07 |
95 |
SPROUTING ANGIOGENESIS |
15 |
45 |
6.65e-09 |
3.257e-07 |
96 |
IMMUNE RESPONSE |
105 |
1100 |
7.444e-09 |
3.608e-07 |
97 |
EMBRYO DEVELOPMENT |
90 |
894 |
7.824e-09 |
3.753e-07 |
98 |
LYMPHOCYTE DIFFERENTIATION |
34 |
209 |
8.104e-09 |
3.848e-07 |
99 |
ORGAN MORPHOGENESIS |
86 |
841 |
8.285e-09 |
3.894e-07 |
100 |
POSITIVE REGULATION OF KINASE ACTIVITY |
58 |
482 |
9.273e-09 |
4.315e-07 |
101 |
CELL PROLIFERATION |
73 |
672 |
9.803e-09 |
4.516e-07 |
102 |
REGULATION OF CELL SIZE |
30 |
172 |
1.181e-08 |
5.39e-07 |
103 |
CELL MORPHOGENESIS INVOLVED IN NEURON DIFFERENTIATION |
48 |
368 |
1.432e-08 |
6.469e-07 |
104 |
POSITIVE REGULATION OF CELL ACTIVATION |
43 |
311 |
1.459e-08 |
6.527e-07 |
105 |
REGULATION OF EXTENT OF CELL GROWTH |
22 |
101 |
1.677e-08 |
7.43e-07 |
106 |
REGULATION OF EPITHELIAL CELL MIGRATION |
29 |
166 |
1.988e-08 |
8.727e-07 |
107 |
RESPONSE TO OXYGEN CONTAINING COMPOUND |
123 |
1381 |
2.128e-08 |
9.253e-07 |
108 |
WOUND HEALING |
56 |
470 |
2.368e-08 |
1.02e-06 |
109 |
NEURON PROJECTION DEVELOPMENT |
62 |
545 |
2.419e-08 |
1.033e-06 |
110 |
EPITHELIUM DEVELOPMENT |
92 |
945 |
2.673e-08 |
1.131e-06 |
111 |
REGULATION OF ANATOMICAL STRUCTURE SIZE |
56 |
472 |
2.747e-08 |
1.151e-06 |
112 |
REGULATION OF TRANSFERASE ACTIVITY |
92 |
946 |
2.811e-08 |
1.168e-06 |
113 |
CYTOSKELETON ORGANIZATION |
84 |
838 |
3.072e-08 |
1.265e-06 |
114 |
NEURON PROJECTION MORPHOGENESIS |
50 |
402 |
3.418e-08 |
1.383e-06 |
115 |
STEM CELL DIFFERENTIATION |
31 |
190 |
3.419e-08 |
1.383e-06 |
116 |
POSITIVE REGULATION OF CELL CELL ADHESION |
36 |
243 |
3.676e-08 |
1.475e-06 |
117 |
REGULATION OF T HELPER CELL DIFFERENTIATION |
11 |
26 |
3.988e-08 |
1.586e-06 |
118 |
NEURON DIFFERENTIATION |
86 |
874 |
4.839e-08 |
1.908e-06 |
119 |
CELLULAR RESPONSE TO BIOTIC STIMULUS |
28 |
163 |
5.057e-08 |
1.977e-06 |
120 |
ENDOTHELIUM DEVELOPMENT |
20 |
90 |
5.222e-08 |
2.025e-06 |
121 |
POSITIVE REGULATION OF LOCOMOTION |
51 |
420 |
5.457e-08 |
2.099e-06 |
122 |
REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY |
55 |
470 |
5.844e-08 |
2.229e-06 |
123 |
EXTRACELLULAR STRUCTURE ORGANIZATION |
41 |
304 |
6.372e-08 |
2.411e-06 |
124 |
CHONDROCYTE DIFFERENTIATION |
16 |
60 |
7.478e-08 |
2.806e-06 |
125 |
NEGATIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT |
37 |
262 |
8.485e-08 |
3.158e-06 |
126 |
CENTRAL NERVOUS SYSTEM DEVELOPMENT |
85 |
872 |
8.799e-08 |
3.249e-06 |
127 |
CELLULAR COMPONENT MORPHOGENESIS |
87 |
900 |
8.946e-08 |
3.278e-06 |
128 |
NEGATIVE REGULATION OF LOCOMOTION |
37 |
263 |
9.372e-08 |
3.407e-06 |
129 |
CELL CYCLE |
116 |
1316 |
9.75e-08 |
3.517e-06 |
130 |
CELL PROJECTION ORGANIZATION |
87 |
902 |
9.873e-08 |
3.534e-06 |
131 |
RESPONSE TO MOLECULE OF BACTERIAL ORIGIN |
42 |
321 |
1.045e-07 |
3.712e-06 |
132 |
NEURON DEVELOPMENT |
71 |
687 |
1.153e-07 |
4.063e-06 |
133 |
POSITIVE REGULATION OF T HELPER CELL DIFFERENTIATION |
9 |
18 |
1.189e-07 |
4.161e-06 |
134 |
REGULATION OF DEVELOPMENTAL GROWTH |
39 |
289 |
1.309e-07 |
4.545e-06 |
135 |
CELLULAR RESPONSE TO LIPID |
53 |
457 |
1.363e-07 |
4.698e-06 |
136 |
REGULATION OF ENDOTHELIAL CELL MIGRATION |
22 |
114 |
1.662e-07 |
5.686e-06 |
137 |
MORPHOGENESIS OF AN EPITHELIUM |
48 |
400 |
1.92e-07 |
6.522e-06 |
138 |
RESPONSE TO GROWTH FACTOR |
54 |
475 |
1.993e-07 |
6.721e-06 |
139 |
REGULATION OF LEUKOCYTE PROLIFERATION |
31 |
206 |
2.253e-07 |
7.54e-06 |
140 |
CELL CYCLE PROCESS |
98 |
1081 |
2.896e-07 |
9.626e-06 |
141 |
RESPONSE TO ENDOGENOUS STIMULUS |
123 |
1450 |
3.137e-07 |
1.028e-05 |
142 |
MORPHOGENESIS OF A BRANCHING STRUCTURE |
27 |
167 |
3.121e-07 |
1.028e-05 |
143 |
MUSCLE STRUCTURE DEVELOPMENT |
50 |
432 |
3.274e-07 |
1.065e-05 |
144 |
REGULATION OF T HELPER 2 CELL DIFFERENTIATION |
7 |
11 |
3.602e-07 |
1.16e-05 |
145 |
MYELOID CELL DIFFERENTIATION |
29 |
189 |
3.616e-07 |
1.16e-05 |
146 |
CELL DEATH |
92 |
1001 |
3.748e-07 |
1.186e-05 |
147 |
REGULATION OF TRANSPORT |
146 |
1804 |
3.745e-07 |
1.186e-05 |
148 |
RESPONSE TO LIPID |
84 |
888 |
3.774e-07 |
1.186e-05 |
149 |
REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION |
37 |
278 |
3.876e-07 |
1.21e-05 |
150 |
NEGATIVE REGULATION OF DEVELOPMENTAL GROWTH |
18 |
84 |
4.301e-07 |
1.317e-05 |
151 |
REGULATION OF HEMOPOIESIS |
40 |
314 |
4.262e-07 |
1.317e-05 |
152 |
REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION |
12 |
38 |
4.279e-07 |
1.317e-05 |
153 |
NEGATIVE REGULATION OF NEURON DIFFERENTIATION |
29 |
191 |
4.534e-07 |
1.363e-05 |
154 |
TUBE DEVELOPMENT |
59 |
552 |
4.541e-07 |
1.363e-05 |
155 |
RESPONSE TO REACTIVE OXYGEN SPECIES |
29 |
191 |
4.534e-07 |
1.363e-05 |
156 |
NEGATIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER |
73 |
740 |
4.693e-07 |
1.4e-05 |
157 |
REGULATION OF ALPHA BETA T CELL ACTIVATION |
16 |
68 |
4.883e-07 |
1.443e-05 |
158 |
REGULATION OF TYPE 2 IMMUNE RESPONSE |
10 |
26 |
4.899e-07 |
1.443e-05 |
159 |
ENDOCARDIAL CUSHION DEVELOPMENT |
11 |
32 |
4.933e-07 |
1.444e-05 |
160 |
EMBRYO DEVELOPMENT ENDING IN BIRTH OR EGG HATCHING |
59 |
554 |
5.124e-07 |
1.49e-05 |
161 |
NEGATIVE REGULATION OF GROWTH |
33 |
236 |
5.278e-07 |
1.525e-05 |
162 |
ENZYME LINKED RECEPTOR PROTEIN SIGNALING PATHWAY |
69 |
689 |
5.633e-07 |
1.618e-05 |
163 |
REGULATION OF ALPHA BETA T CELL DIFFERENTIATION |
13 |
46 |
5.994e-07 |
1.711e-05 |
164 |
CONNECTIVE TISSUE DEVELOPMENT |
29 |
194 |
6.323e-07 |
1.794e-05 |
165 |
REGULATION OF MAP KINASE ACTIVITY |
40 |
319 |
6.443e-07 |
1.815e-05 |
166 |
NEURON PROJECTION GUIDANCE |
30 |
205 |
6.474e-07 |
1.815e-05 |
167 |
T CELL DIFFERENTIATION |
22 |
123 |
6.58e-07 |
1.833e-05 |
168 |
NEGATIVE REGULATION OF CELL DEATH |
82 |
872 |
6.64e-07 |
1.839e-05 |
169 |
POSITIVE REGULATION OF VASCULATURE DEVELOPMENT |
23 |
133 |
6.865e-07 |
1.89e-05 |
170 |
LYMPHOCYTE COSTIMULATION |
17 |
78 |
6.947e-07 |
1.902e-05 |
171 |
POSITIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION |
10 |
27 |
7.405e-07 |
2.015e-05 |
172 |
FOREBRAIN DEVELOPMENT |
43 |
357 |
7.475e-07 |
2.022e-05 |
173 |
NEGATIVE REGULATION OF CELL PROJECTION ORGANIZATION |
24 |
144 |
7.937e-07 |
2.135e-05 |
174 |
REGULATION OF HYDROLASE ACTIVITY |
113 |
1327 |
8.23e-07 |
2.201e-05 |
175 |
MUSCLE TISSUE DEVELOPMENT |
36 |
275 |
8.296e-07 |
2.206e-05 |
176 |
POSITIVE REGULATION OF IMMUNE RESPONSE |
59 |
563 |
8.731e-07 |
2.308e-05 |
177 |
TUBE MORPHOGENESIS |
40 |
323 |
8.896e-07 |
2.336e-05 |
178 |
TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE SIGNALING PATHWAY |
54 |
498 |
8.936e-07 |
2.336e-05 |
179 |
CELL CELL SIGNALING |
74 |
767 |
9.129e-07 |
2.373e-05 |
180 |
HEART VALVE DEVELOPMENT |
11 |
34 |
9.899e-07 |
2.559e-05 |
181 |
POSITIVE REGULATION OF LEUKOCYTE PROLIFERATION |
23 |
136 |
1.03e-06 |
2.647e-05 |
182 |
RESPONSE TO MECHANICAL STIMULUS |
30 |
210 |
1.088e-06 |
2.781e-05 |
183 |
ACTIVATION OF PROTEIN KINASE ACTIVITY |
36 |
279 |
1.174e-06 |
2.985e-05 |
184 |
NEGATIVE REGULATION OF CELL DEVELOPMENT |
38 |
303 |
1.216e-06 |
3.074e-05 |
185 |
SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION |
42 |
352 |
1.286e-06 |
3.234e-05 |
186 |
RESPONSE TO ORGANIC CYCLIC COMPOUND |
84 |
917 |
1.408e-06 |
3.521e-05 |
187 |
POSITIVE REGULATION OF TRANSFERASE ACTIVITY |
62 |
616 |
1.798e-06 |
4.475e-05 |
188 |
REGULATION OF ERK1 AND ERK2 CASCADE |
32 |
238 |
1.866e-06 |
4.618e-05 |
189 |
SEMAPHORIN PLEXIN SIGNALING PATHWAY |
11 |
36 |
1.881e-06 |
4.632e-05 |
190 |
NEURAL CREST CELL DIFFERENTIATION |
16 |
75 |
1.988e-06 |
4.869e-05 |
191 |
TELENCEPHALON DEVELOPMENT |
31 |
228 |
2.119e-06 |
5.163e-05 |
192 |
PLATELET ACTIVATION |
23 |
142 |
2.227e-06 |
5.369e-05 |
193 |
ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY |
28 |
195 |
2.22e-06 |
5.369e-05 |
194 |
POSITIVE REGULATION OF CELL CYCLE ARREST |
17 |
85 |
2.474e-06 |
5.933e-05 |
195 |
ACTIN FILAMENT BASED PROCESS |
49 |
450 |
2.53e-06 |
6.037e-05 |
196 |
POSITIVE REGULATION OF ALPHA BETA T CELL DIFFERENTIATION |
11 |
37 |
2.547e-06 |
6.047e-05 |
197 |
CELL CYCLE PHASE TRANSITION |
33 |
255 |
3.034e-06 |
7.167e-05 |
198 |
REGULATION OF LEUKOCYTE DIFFERENTIATION |
31 |
232 |
3.068e-06 |
7.209e-05 |
199 |
HEAD DEVELOPMENT |
68 |
709 |
3.118e-06 |
7.291e-05 |
200 |
CEREBRAL CORTEX DEVELOPMENT |
19 |
105 |
3.134e-06 |
7.292e-05 |
201 |
POSITIVE REGULATION OF INTERLEUKIN 2 PRODUCTION |
10 |
31 |
3.193e-06 |
7.392e-05 |
202 |
POSITIVE REGULATION OF AXONOGENESIS |
15 |
69 |
3.223e-06 |
7.423e-05 |
203 |
POSITIVE REGULATION OF TYPE 2 IMMUNE RESPONSE |
7 |
14 |
3.244e-06 |
7.436e-05 |
204 |
NEGATIVE REGULATION OF AXON EXTENSION |
11 |
38 |
3.411e-06 |
7.779e-05 |
205 |
SKELETAL SYSTEM DEVELOPMENT |
49 |
455 |
3.453e-06 |
7.837e-05 |
206 |
CARTILAGE DEVELOPMENT |
23 |
147 |
4.08e-06 |
9.217e-05 |
207 |
REGULATION OF T CELL DIFFERENTIATION |
19 |
107 |
4.191e-06 |
9.42e-05 |
208 |
REGULATION OF GROWTH |
62 |
633 |
4.364e-06 |
9.763e-05 |
209 |
PATTERNING OF BLOOD VESSELS |
10 |
32 |
4.42e-06 |
9.794e-05 |
210 |
PROTEIN PHOSPHORYLATION |
84 |
944 |
4.408e-06 |
9.794e-05 |
211 |
POSITIVE REGULATION OF CELL CYCLE |
39 |
332 |
4.457e-06 |
9.828e-05 |
212 |
REGULATION OF AXON GUIDANCE |
11 |
39 |
4.52e-06 |
9.92e-05 |
213 |
REGULATION OF CARTILAGE DEVELOPMENT |
14 |
63 |
5.189e-06 |
0.0001134 |
214 |
CELLULAR RESPONSE TO STRESS |
125 |
1565 |
5.492e-06 |
0.0001194 |
215 |
RESPONSE TO MURAMYL DIPEPTIDE |
7 |
15 |
5.798e-06 |
0.0001251 |
216 |
RESPONSE TO OXYGEN LEVELS |
37 |
311 |
5.807e-06 |
0.0001251 |
217 |
OSSIFICATION |
32 |
251 |
5.857e-06 |
0.0001256 |
218 |
CELL CYCLE CHECKPOINT |
27 |
194 |
6.09e-06 |
0.00013 |
219 |
MITOTIC CELL CYCLE |
71 |
766 |
6.26e-06 |
0.000133 |
220 |
REGULATION OF CELLULAR COMPONENT SIZE |
39 |
337 |
6.375e-06 |
0.0001348 |
221 |
REGULATION OF INTERLEUKIN 2 PRODUCTION |
12 |
48 |
6.667e-06 |
0.0001404 |
222 |
POSITIVE REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION |
24 |
162 |
6.708e-06 |
0.0001406 |
223 |
INFLAMMATORY RESPONSE |
48 |
454 |
7.153e-06 |
0.0001491 |
224 |
BRANCHING MORPHOGENESIS OF AN EPITHELIAL TUBE |
21 |
131 |
7.176e-06 |
0.0001491 |
225 |
CELL CYCLE G1 S PHASE TRANSITION |
19 |
111 |
7.318e-06 |
0.0001507 |
226 |
G1 S TRANSITION OF MITOTIC CELL CYCLE |
19 |
111 |
7.318e-06 |
0.0001507 |
227 |
RESPONSE TO OXIDATIVE STRESS |
40 |
352 |
7.574e-06 |
0.0001553 |
228 |
CHONDROCYTE DEVELOPMENT |
8 |
21 |
7.678e-06 |
0.000156 |
229 |
NEGATIVE REGULATION OF AXONOGENESIS |
14 |
65 |
7.652e-06 |
0.000156 |
230 |
REGULATION OF GTPASE ACTIVITY |
64 |
673 |
7.999e-06 |
0.0001618 |
231 |
REGULATION OF CYTOKINE PRODUCTION |
56 |
563 |
8.051e-06 |
0.0001622 |
232 |
REGULATION OF CELL CYCLE |
83 |
949 |
9.636e-06 |
0.0001933 |
233 |
CELLULAR RESPONSE TO ENDOGENOUS STIMULUS |
87 |
1008 |
9.75e-06 |
0.0001947 |
234 |
POSITIVE REGULATION OF TRANSPORT |
82 |
936 |
1.026e-05 |
0.0002041 |
235 |
DEVELOPMENTAL GROWTH INVOLVED IN MORPHOGENESIS |
18 |
104 |
1.079e-05 |
0.0002136 |
236 |
LEUKOCYTE MIGRATION |
32 |
259 |
1.127e-05 |
0.0002222 |
237 |
HEART MORPHOGENESIS |
28 |
212 |
1.133e-05 |
0.0002225 |
238 |
T CELL RECEPTOR SIGNALING PATHWAY |
22 |
146 |
1.218e-05 |
0.0002361 |
239 |
NEGATIVE REGULATION OF CELL CYCLE PHASE TRANSITION |
22 |
146 |
1.218e-05 |
0.0002361 |
240 |
DNA INTEGRITY CHECKPOINT |
22 |
146 |
1.218e-05 |
0.0002361 |
241 |
REGULATION OF RESPONSE TO EXTERNAL STIMULUS |
81 |
926 |
1.23e-05 |
0.0002375 |
242 |
CHONDROITIN SULFATE PROTEOGLYCAN METABOLIC PROCESS |
11 |
43 |
1.271e-05 |
0.0002444 |
243 |
NEGATIVE REGULATION OF CHEMOTAXIS |
12 |
51 |
1.307e-05 |
0.0002493 |
244 |
POSITIVE REGULATION OF ALPHA BETA T CELL ACTIVATION |
12 |
51 |
1.307e-05 |
0.0002493 |
245 |
NEGATIVE REGULATION OF NITROGEN COMPOUND METABOLIC PROCESS |
120 |
1517 |
1.347e-05 |
0.0002558 |
246 |
POSITIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION |
96 |
1152 |
1.406e-05 |
0.0002658 |
247 |
IN UTERO EMBRYONIC DEVELOPMENT |
36 |
311 |
1.422e-05 |
0.000268 |
248 |
TISSUE REMODELING |
16 |
87 |
1.496e-05 |
0.0002807 |
249 |
NEGATIVE REGULATION OF CELL GROWTH |
24 |
170 |
1.542e-05 |
0.0002882 |
250 |
NEGATIVE REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION |
19 |
117 |
1.599e-05 |
0.0002977 |
251 |
ADAPTIVE IMMUNE RESPONSE |
34 |
288 |
1.614e-05 |
0.0002993 |
252 |
NEGATIVE REGULATION OF MULTICELLULAR ORGANISMAL METABOLIC PROCESS |
6 |
12 |
1.714e-05 |
0.0003165 |
253 |
REGULATION OF STEM CELL PROLIFERATION |
16 |
88 |
1.738e-05 |
0.0003196 |
254 |
NEGATIVE REGULATION OF CELL CYCLE G1 S PHASE TRANSITION |
17 |
98 |
1.825e-05 |
0.000333 |
255 |
REGULATION OF ENDOTHELIAL CELL PROLIFERATION |
17 |
98 |
1.825e-05 |
0.000333 |
256 |
MULTICELLULAR ORGANISMAL MACROMOLECULE METABOLIC PROCESS |
15 |
79 |
1.846e-05 |
0.0003343 |
257 |
REGULATION OF CELL CYCLE ARREST |
18 |
108 |
1.845e-05 |
0.0003343 |
258 |
AXON EXTENSION |
10 |
37 |
1.864e-05 |
0.0003362 |
259 |
INTERFERON GAMMA MEDIATED SIGNALING PATHWAY |
14 |
70 |
1.884e-05 |
0.0003371 |
260 |
CENTRAL NERVOUS SYSTEM NEURON DEVELOPMENT |
14 |
70 |
1.884e-05 |
0.0003371 |
261 |
SMOOTH MUSCLE CELL DIFFERENTIATION |
9 |
30 |
1.942e-05 |
0.0003434 |
262 |
CHONDROITIN SULFATE PROTEOGLYCAN BIOSYNTHETIC PROCESS |
9 |
30 |
1.942e-05 |
0.0003434 |
263 |
CELLULAR RESPONSE TO VASCULAR ENDOTHELIAL GROWTH FACTOR STIMULUS |
9 |
30 |
1.942e-05 |
0.0003434 |
264 |
POSITIVE REGULATION OF CELL PROJECTION ORGANIZATION |
35 |
303 |
1.948e-05 |
0.0003434 |
265 |
NEURON PROJECTION EXTENSION |
12 |
53 |
1.988e-05 |
0.0003491 |
266 |
CENTROSOME CYCLE |
11 |
45 |
2.031e-05 |
0.0003552 |
267 |
REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION |
18 |
109 |
2.1e-05 |
0.0003659 |
268 |
CARDIAC VENTRICLE MORPHOGENESIS |
13 |
62 |
2.187e-05 |
0.0003796 |
269 |
POSITIVE REGULATION OF NEURON PROJECTION DEVELOPMENT |
29 |
232 |
2.297e-05 |
0.0003973 |
270 |
REGULATION OF GLIOGENESIS |
16 |
90 |
2.328e-05 |
0.0004012 |
271 |
CELL SUBSTRATE ADHESION |
23 |
164 |
2.566e-05 |
0.0004396 |
272 |
PALLIUM DEVELOPMENT |
22 |
153 |
2.579e-05 |
0.0004396 |
273 |
HOMOPHILIC CELL ADHESION VIA PLASMA MEMBRANE ADHESION MOLECULES |
22 |
153 |
2.579e-05 |
0.0004396 |
274 |
REGULATION OF CELLULAR LOCALIZATION |
103 |
1277 |
2.631e-05 |
0.0004469 |
275 |
RESPONSE TO NITROGEN COMPOUND |
75 |
859 |
2.758e-05 |
0.000465 |
276 |
REGULATION OF LYMPHOCYTE DIFFERENTIATION |
20 |
132 |
2.754e-05 |
0.000465 |
277 |
SEMAPHORIN PLEXIN SIGNALING PATHWAY INVOLVED IN NEURON PROJECTION GUIDANCE |
6 |
13 |
3.038e-05 |
0.0005103 |
278 |
REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION |
14 |
73 |
3.098e-05 |
0.0005185 |
279 |
ACTIVATION OF IMMUNE RESPONSE |
44 |
427 |
3.192e-05 |
0.0005323 |
280 |
CELL PART MORPHOGENESIS |
59 |
633 |
3.232e-05 |
0.0005351 |
281 |
IMMUNE RESPONSE REGULATING CELL SURFACE RECEPTOR SIGNALING PATHWAY |
36 |
323 |
3.229e-05 |
0.0005351 |
282 |
MEMBRANE ASSEMBLY |
8 |
25 |
3.362e-05 |
0.0005528 |
283 |
CHONDROITIN SULFATE BIOSYNTHETIC PROCESS |
8 |
25 |
3.362e-05 |
0.0005528 |
284 |
ANTIGEN PROCESSING AND PRESENTATION |
27 |
213 |
3.389e-05 |
0.0005553 |
285 |
PROTEOGLYCAN METABOLIC PROCESS |
15 |
83 |
3.403e-05 |
0.0005555 |
286 |
MUSCLE CELL DIFFERENTIATION |
29 |
237 |
3.425e-05 |
0.0005573 |
287 |
TISSUE MIGRATION |
15 |
84 |
3.938e-05 |
0.0006363 |
288 |
MICROTUBULE ORGANIZING CENTER ORGANIZATION |
15 |
84 |
3.938e-05 |
0.0006363 |
289 |
POSITIVE REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY |
33 |
289 |
4.201e-05 |
0.0006763 |
290 |
ARTERY DEVELOPMENT |
14 |
75 |
4.247e-05 |
0.0006815 |
291 |
NEGATIVE REGULATION OF CELL ACTIVATION |
22 |
158 |
4.266e-05 |
0.0006821 |
292 |
RESPONSE TO BACTERIUM |
51 |
528 |
4.401e-05 |
0.0007013 |
293 |
NEGATIVE REGULATION OF CELL CYCLE |
44 |
433 |
4.457e-05 |
0.0007078 |
294 |
REGULATION OF TOLL LIKE RECEPTOR SIGNALING PATHWAY |
11 |
49 |
4.779e-05 |
0.0007564 |
295 |
REGULATION OF RESPONSE TO STRESS |
114 |
1468 |
4.95e-05 |
0.0007782 |
296 |
EXTRACELLULAR MATRIX DISASSEMBLY |
14 |
76 |
4.951e-05 |
0.0007782 |
297 |
VASCULAR ENDOTHELIAL GROWTH FACTOR SIGNALING PATHWAY |
6 |
14 |
5.073e-05 |
0.0007948 |
298 |
SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR |
19 |
127 |
5.18e-05 |
0.0008089 |
299 |
POSITIVE REGULATION OF CYTOKINE PRODUCTION |
39 |
370 |
5.393e-05 |
0.0008393 |
300 |
LEUKOCYTE CHEMOTAXIS |
18 |
117 |
5.562e-05 |
0.0008627 |
301 |
DEVELOPMENTAL CELL GROWTH |
14 |
77 |
5.754e-05 |
0.0008895 |
302 |
POSITIVE REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION |
10 |
42 |
6.154e-05 |
0.0009482 |
303 |
CENTRAL NERVOUS SYSTEM NEURON AXONOGENESIS |
8 |
27 |
6.266e-05 |
0.0009622 |
304 |
NEGATIVE REGULATION OF GENE EXPRESSION |
115 |
1493 |
6.445e-05 |
0.0009865 |
305 |
CARDIAC MUSCLE TISSUE DEVELOPMENT |
20 |
140 |
6.497e-05 |
0.0009879 |
306 |
REGULATION OF ION TRANSPORT |
55 |
592 |
6.478e-05 |
0.0009879 |
307 |
ACTIN FILAMENT ORGANIZATION |
23 |
174 |
6.597e-05 |
0.0009999 |
308 |
POSITIVE REGULATION OF HEMOPOIESIS |
22 |
163 |
6.88e-05 |
0.001039 |
309 |
PROTEIN COMPLEX SUBUNIT ORGANIZATION |
117 |
1527 |
6.925e-05 |
0.001043 |
310 |
ARTERY MORPHOGENESIS |
11 |
51 |
7.074e-05 |
0.001058 |
311 |
REGULATION OF BLOOD VESSEL ENDOTHELIAL CELL MIGRATION |
11 |
51 |
7.074e-05 |
0.001058 |
312 |
TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER |
64 |
724 |
7.444e-05 |
0.001107 |
313 |
RESPONSE TO HYDROGEN PEROXIDE |
17 |
109 |
7.445e-05 |
0.001107 |
314 |
CEREBRAL CORTEX CELL MIGRATION |
10 |
43 |
7.634e-05 |
0.001131 |
315 |
POSITIVE REGULATION OF LEUKOCYTE DIFFERENTIATION |
19 |
131 |
7.967e-05 |
0.001177 |
316 |
CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS |
6 |
15 |
8.069e-05 |
0.001188 |
317 |
UROGENITAL SYSTEM DEVELOPMENT |
33 |
299 |
8.205e-05 |
0.001204 |
318 |
ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE ANTIGEN |
23 |
177 |
8.607e-05 |
0.001252 |
319 |
POSITIVE REGULATION OF EPITHELIAL CELL PROLIFERATION |
21 |
154 |
8.586e-05 |
0.001252 |
320 |
AMEBOIDAL TYPE CELL MIGRATION |
21 |
154 |
8.586e-05 |
0.001252 |
321 |
RAS PROTEIN SIGNAL TRANSDUCTION |
20 |
143 |
8.787e-05 |
0.00127 |
322 |
MITOTIC DNA INTEGRITY CHECKPOINT |
16 |
100 |
8.791e-05 |
0.00127 |
323 |
POSITIVE REGULATION OF LYMPHOCYTE DIFFERENTIATION |
14 |
80 |
8.884e-05 |
0.00128 |
324 |
CENTRAL NERVOUS SYSTEM NEURON DIFFERENTIATION |
22 |
166 |
9.061e-05 |
0.001301 |
325 |
CIRCULATORY SYSTEM PROCESS |
38 |
366 |
9.211e-05 |
0.001319 |
326 |
REGULATION OF OSSIFICATION |
23 |
178 |
9.389e-05 |
0.00134 |
327 |
POSITIVE REGULATION OF AXON EXTENSION |
9 |
36 |
9.53e-05 |
0.001352 |
328 |
T CELL SELECTION |
9 |
36 |
9.53e-05 |
0.001352 |
329 |
NEGATIVE REGULATION OF CELL CYCLE PROCESS |
26 |
214 |
9.623e-05 |
0.001361 |
330 |
REGULATION OF TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION |
16 |
101 |
9.93e-05 |
0.0014 |
331 |
POSITIVE REGULATION OF I KAPPAB KINASE NF KAPPAB SIGNALING |
23 |
179 |
0.0001023 |
0.001439 |
332 |
FOREBRAIN CELL MIGRATION |
12 |
62 |
0.0001027 |
0.00144 |
333 |
SYNAPSE ORGANIZATION |
20 |
145 |
0.0001069 |
0.001493 |
334 |
CENTRAL NERVOUS SYSTEM PROJECTION NEURON AXONOGENESIS |
7 |
22 |
0.00011 |
0.001528 |
335 |
POSITIVE REGULATION OF INTERLEUKIN 4 PRODUCTION |
7 |
22 |
0.00011 |
0.001528 |
336 |
ENDOTHELIAL CELL DIFFERENTIATION |
13 |
72 |
0.000113 |
0.001565 |
337 |
ATRIOVENTRICULAR VALVE MORPHOGENESIS |
6 |
16 |
0.0001232 |
0.001701 |
338 |
POSITIVE REGULATION OF EPITHELIAL CELL MIGRATION |
16 |
103 |
0.000126 |
0.001735 |
339 |
REGULATION OF CELL CYCLE G1 S PHASE TRANSITION |
20 |
147 |
0.0001294 |
0.001776 |
340 |
EPITHELIAL CELL DIFFERENTIATION |
47 |
495 |
0.0001301 |
0.001781 |
341 |
G1 DNA DAMAGE CHECKPOINT |
13 |
73 |
0.0001308 |
0.001785 |
342 |
MULTICELLULAR ORGANISM METABOLIC PROCESS |
15 |
93 |
0.0001319 |
0.001794 |
343 |
CARDIAC CHAMBER MORPHOGENESIS |
16 |
104 |
0.0001416 |
0.001909 |
344 |
REGULATION OF INTERLEUKIN 6 PRODUCTION |
16 |
104 |
0.0001416 |
0.001909 |
345 |
CELLULAR RESPONSE TO REACTIVE OXYGEN SPECIES |
16 |
104 |
0.0001416 |
0.001909 |
346 |
MEMBRANE BIOGENESIS |
8 |
30 |
0.0001429 |
0.001917 |
347 |
OSTEOCLAST DIFFERENTIATION |
8 |
30 |
0.0001429 |
0.001917 |
348 |
NEGATIVE REGULATION OF EPITHELIAL CELL PROLIFERATION |
17 |
115 |
0.0001468 |
0.001962 |
349 |
ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE OR POLYSACCHARIDE ANTIGEN VIA MHC CLASS II |
15 |
94 |
0.0001492 |
0.001983 |
350 |
ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE ANTIGEN VIA MHC CLASS II |
15 |
94 |
0.0001492 |
0.001983 |
351 |
REGULATION OF MULTICELLULAR ORGANISMAL METABOLIC PROCESS |
9 |
38 |
0.0001497 |
0.001984 |
352 |
VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY |
13 |
74 |
0.000151 |
0.001995 |
353 |
POSITIVE REGULATION OF RESPONSE TO EXTERNAL STIMULUS |
32 |
296 |
0.0001537 |
0.002014 |
354 |
POSITIVE REGULATION OF ERK1 AND ERK2 CASCADE |
22 |
172 |
0.0001534 |
0.002014 |
355 |
NEGATIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION |
60 |
684 |
0.0001529 |
0.002014 |
356 |
CELLULAR RESPONSE TO OXIDATIVE STRESS |
23 |
184 |
0.0001556 |
0.002033 |
357 |
REGULATION OF I KAPPAB KINASE NF KAPPAB SIGNALING |
27 |
233 |
0.0001587 |
0.002069 |
358 |
POSITIVE REGULATION OF T CELL PROLIFERATION |
15 |
95 |
0.0001684 |
0.002187 |
359 |
CELL JUNCTION ORGANIZATION |
23 |
185 |
0.0001688 |
0.002187 |
360 |
EPITHELIAL TO MESENCHYMAL TRANSITION |
11 |
56 |
0.0001727 |
0.002232 |
361 |
HEMOSTASIS |
33 |
311 |
0.0001736 |
0.002238 |
362 |
POSITIVE REGULATION OF CELL CYCLE PROCESS |
28 |
247 |
0.0001761 |
0.002263 |
363 |
REGULATION OF CELL CYCLE PROCESS |
51 |
558 |
0.0001766 |
0.002264 |
364 |
CELL CHEMOTAXIS |
21 |
162 |
0.0001778 |
0.002272 |
365 |
REGULATION OF INTERLEUKIN 4 PRODUCTION |
8 |
31 |
0.0001836 |
0.00234 |
366 |
NEGATIVE CHEMOTAXIS |
9 |
39 |
0.0001853 |
0.002356 |
367 |
NEGATIVE REGULATION OF RESPONSE TO EXTERNAL STIMULUS |
30 |
274 |
0.0001951 |
0.002474 |
368 |
REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT |
10 |
48 |
0.0002037 |
0.002555 |
369 |
ENDOTHELIAL CELL MIGRATION |
11 |
57 |
0.0002037 |
0.002555 |
370 |
BLOOD VESSEL ENDOTHELIAL CELL MIGRATION |
7 |
24 |
0.000203 |
0.002555 |
371 |
CARDIAC EPITHELIAL TO MESENCHYMAL TRANSITION |
7 |
24 |
0.000203 |
0.002555 |
372 |
RESPONSE TO BIOTIC STIMULUS |
73 |
886 |
0.000215 |
0.002689 |
373 |
REGULATION OF DNA TEMPLATED TRANSCRIPTION IN RESPONSE TO STRESS |
12 |
67 |
0.0002224 |
0.002767 |
374 |
MUCOPOLYSACCHARIDE METABOLIC PROCESS |
16 |
108 |
0.0002218 |
0.002767 |
375 |
SENSORY ORGAN DEVELOPMENT |
46 |
493 |
0.0002275 |
0.002822 |
376 |
GROWTH |
40 |
410 |
0.0002307 |
0.002855 |
377 |
BLOOD VESSEL REMODELING |
8 |
32 |
0.0002333 |
0.002879 |
378 |
MUSCLE ORGAN DEVELOPMENT |
30 |
277 |
0.000236 |
0.002905 |
379 |
POSITIVE REGULATION OF CHEMOTAXIS |
17 |
120 |
0.000248 |
0.003044 |
380 |
CELL FATE COMMITMENT |
26 |
227 |
0.0002508 |
0.003071 |
381 |
CELLULAR RESPONSE TO HORMONE STIMULUS |
50 |
552 |
0.0002521 |
0.003078 |
382 |
LEUKOCYTE PROLIFERATION |
14 |
88 |
0.0002535 |
0.003088 |
383 |
REGULATION OF CELL JUNCTION ASSEMBLY |
12 |
68 |
0.000257 |
0.003114 |
384 |
POSITIVE REGULATION OF ENDOTHELIAL CELL PROLIFERATION |
12 |
68 |
0.000257 |
0.003114 |
385 |
REGULATION OF TOLL LIKE RECEPTOR 4 SIGNALING PATHWAY |
6 |
18 |
0.0002602 |
0.003144 |
386 |
REGULATION OF MITOTIC CELL CYCLE |
44 |
468 |
0.0002617 |
0.003155 |
387 |
EMBRYONIC MORPHOGENESIS |
49 |
539 |
0.0002661 |
0.0032 |
388 |
DEFENSE RESPONSE |
95 |
1231 |
0.0002672 |
0.003204 |
389 |
POSITIVE REGULATION OF NF KAPPAB TRANSCRIPTION FACTOR ACTIVITY |
18 |
132 |
0.000268 |
0.003206 |
390 |
CELL CELL ADHESION VIA PLASMA MEMBRANE ADHESION MOLECULES |
24 |
204 |
0.0002865 |
0.003418 |
391 |
REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS |
26 |
229 |
0.0002881 |
0.003428 |
392 |
BONE DEVELOPMENT |
20 |
156 |
0.0002911 |
0.003438 |
393 |
POSITIVE REGULATION OF DEVELOPMENTAL GROWTH |
20 |
156 |
0.0002911 |
0.003438 |
394 |
POSITIVE REGULATION OF IMMUNE EFFECTOR PROCESS |
20 |
156 |
0.0002911 |
0.003438 |
395 |
LOCALIZATION WITHIN MEMBRANE |
17 |
122 |
0.0003029 |
0.003568 |
396 |
RESPONSE TO IONIZING RADIATION |
19 |
145 |
0.0003087 |
0.003627 |
397 |
PATTERN SPECIFICATION PROCESS |
40 |
418 |
0.0003427 |
0.004017 |
398 |
REGULATION OF CELL GROWTH |
38 |
391 |
0.0003527 |
0.004124 |
399 |
POSITIVE REGULATION OF MAP KINASE ACTIVITY |
24 |
207 |
0.0003561 |
0.004153 |
400 |
REGULATION OF CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS |
6 |
19 |
0.0003629 |
0.004211 |
401 |
ATRIOVENTRICULAR VALVE DEVELOPMENT |
6 |
19 |
0.0003629 |
0.004211 |
402 |
REGULATION OF CELLULAR COMPONENT BIOGENESIS |
64 |
767 |
0.0003718 |
0.004304 |
403 |
PROTEIN OLIGOMERIZATION |
41 |
434 |
0.0003789 |
0.004353 |
404 |
POSITIVE REGULATION OF STEM CELL PROLIFERATION |
11 |
61 |
0.0003788 |
0.004353 |
405 |
PHOSPHORYLATION |
94 |
1228 |
0.0003787 |
0.004353 |
406 |
REGULATION OF PROTEIN LOCALIZATION |
76 |
950 |
0.00039 |
0.004469 |
407 |
REGULATION OF RAS PROTEIN SIGNAL TRANSDUCTION |
22 |
184 |
0.0004025 |
0.004602 |
408 |
ACTIVATION OF MAPKK ACTIVITY |
10 |
52 |
0.0004049 |
0.004618 |
409 |
POSITIVE REGULATION OF INTERLEUKIN 13 PRODUCTION |
5 |
13 |
0.0004084 |
0.004646 |
410 |
NOTCH SIGNALING PATHWAY |
16 |
114 |
0.0004151 |
0.004701 |
411 |
NEGATIVE REGULATION OF PHOSPHORYLATION |
40 |
422 |
0.0004152 |
0.004701 |
412 |
REGULATION OF MUSCLE ORGAN DEVELOPMENT |
15 |
103 |
0.0004165 |
0.004704 |
413 |
NEGATIVE REGULATION OF LEUKOCYTE DIFFERENTIATION |
13 |
82 |
0.0004316 |
0.004862 |
414 |
REGULATION OF LEUKOCYTE MIGRATION |
19 |
149 |
0.0004372 |
0.004902 |
415 |
CELLULAR RESPONSE TO PEPTIDE |
29 |
274 |
0.0004362 |
0.004902 |
416 |
MOTOR NEURON AXON GUIDANCE |
7 |
27 |
0.0004519 |
0.00503 |
417 |
NEGATIVE REGULATION OF AXON GUIDANCE |
7 |
27 |
0.0004519 |
0.00503 |
418 |
REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY |
7 |
27 |
0.0004519 |
0.00503 |
419 |
NEPHRON DEVELOPMENT |
16 |
115 |
0.0004585 |
0.005092 |
420 |
NEGATIVE REGULATION OF CELL CELL ADHESION |
18 |
138 |
0.0004649 |
0.005139 |
421 |
CELL CYCLE G2 M PHASE TRANSITION |
18 |
138 |
0.0004649 |
0.005139 |
422 |
RESPONSE TO CYTOKINE |
60 |
714 |
0.0004697 |
0.005179 |
423 |
NEGATIVE REGULATION OF EPITHELIAL CELL MIGRATION |
10 |
53 |
0.0004753 |
0.005228 |
424 |
POSITIVE REGULATION OF SECRETION |
36 |
370 |
0.0004878 |
0.005353 |
425 |
NEGATIVE REGULATION OF MITOTIC CELL CYCLE |
23 |
199 |
0.0004894 |
0.005358 |
426 |
REGULATION OF MONOCYTE CHEMOTAXIS |
6 |
20 |
0.0004949 |
0.005405 |
427 |
MITOTIC CELL CYCLE CHECKPOINT |
18 |
139 |
0.0005077 |
0.00552 |
428 |
REGULATION OF CELL SHAPE |
18 |
139 |
0.0005077 |
0.00552 |
429 |
NEGATIVE REGULATION OF IMMUNE SYSTEM PROCESS |
36 |
372 |
0.0005392 |
0.005848 |
430 |
REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION |
24 |
213 |
0.0005413 |
0.005857 |
431 |
CELLULAR RESPONSE TO HEAT |
8 |
36 |
0.0005537 |
0.005978 |
432 |
REGULATION OF MUSCLE CELL DIFFERENTIATION |
19 |
152 |
0.000562 |
0.006053 |
433 |
CARDIAC VENTRICLE DEVELOPMENT |
15 |
106 |
0.0005689 |
0.006113 |
434 |
NEGATIVE REGULATION OF DENDRITE DEVELOPMENT |
7 |
28 |
0.0005746 |
0.006146 |
435 |
REGULATION OF SPROUTING ANGIOGENESIS |
7 |
28 |
0.0005746 |
0.006146 |
436 |
ENDOCHONDRAL BONE MORPHOGENESIS |
9 |
45 |
0.0005791 |
0.00618 |
437 |
DEVELOPMENTAL GROWTH |
33 |
333 |
0.0005978 |
0.006365 |
438 |
POSITIVE REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION |
5 |
14 |
0.0006071 |
0.00645 |
439 |
REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION |
13 |
85 |
0.0006155 |
0.006523 |
440 |
MYELOID LEUKOCYTE DIFFERENTIATION |
14 |
96 |
0.0006318 |
0.006666 |
441 |
SIGNAL TRANSDUCTION IN RESPONSE TO DNA DAMAGE |
14 |
96 |
0.0006318 |
0.006666 |
442 |
MICROTUBULE CYTOSKELETON ORGANIZATION |
34 |
348 |
0.0006415 |
0.006753 |
443 |
REGULATION OF B CELL PROLIFERATION |
10 |
55 |
0.0006464 |
0.00679 |
444 |
NEGATIVE REGULATION OF ORGAN GROWTH |
6 |
21 |
0.0006613 |
0.006931 |
445 |
CELL MATRIX ADHESION |
16 |
119 |
0.0006732 |
0.00701 |
446 |
GLIAL CELL MIGRATION |
8 |
37 |
0.0006734 |
0.00701 |
447 |
NEGATIVE REGULATION OF EPITHELIAL CELL DIFFERENTIATION |
8 |
37 |
0.0006734 |
0.00701 |
448 |
REGULATION OF CHONDROCYTE DIFFERENTIATION |
9 |
46 |
0.0006859 |
0.007123 |
449 |
CELLULAR RESPONSE TO OXYGEN LEVELS |
18 |
143 |
0.0007144 |
0.007404 |
450 |
POSITIVE REGULATION OF DEFENSE RESPONSE |
35 |
364 |
0.0007179 |
0.007423 |
451 |
REGULATION OF CARDIAC MUSCLE CELL PROLIFERATION |
7 |
29 |
0.0007224 |
0.007437 |
452 |
CEREBRAL CORTEX RADIALLY ORIENTED CELL MIGRATION |
7 |
29 |
0.0007224 |
0.007437 |
453 |
EMBRYONIC ORGAN DEVELOPMENT |
38 |
406 |
0.0007266 |
0.007464 |
454 |
REGULATION OF BODY FLUID LEVELS |
45 |
506 |
0.0007401 |
0.007568 |
455 |
REGULATION OF DENDRITE DEVELOPMENT |
16 |
120 |
0.0007386 |
0.007568 |
456 |
CARDIAC CHAMBER DEVELOPMENT |
18 |
144 |
0.0007762 |
0.00792 |
457 |
POSITIVE REGULATION OF GLIOGENESIS |
9 |
47 |
0.0008082 |
0.008229 |
458 |
MESENCHYME MORPHOGENESIS |
8 |
38 |
0.0008131 |
0.00826 |
459 |
NEURON MIGRATION |
15 |
110 |
0.000844 |
0.008556 |
460 |
CYTOKINE MEDIATED SIGNALING PATHWAY |
41 |
452 |
0.0008523 |
0.008621 |
461 |
REGULATION OF B CELL RECEPTOR SIGNALING PATHWAY |
5 |
15 |
0.0008703 |
0.008635 |
462 |
REGULATION OF HEAT GENERATION |
5 |
15 |
0.0008703 |
0.008635 |
463 |
NEGATIVE REGULATION OF REGULATED SECRETORY PATHWAY |
6 |
22 |
0.0008681 |
0.008635 |
464 |
ENDOCARDIAL CUSHION MORPHOGENESIS |
6 |
22 |
0.0008681 |
0.008635 |
465 |
POSITIVE REGULATION OF ENDOTHELIAL CELL MIGRATION |
11 |
67 |
0.0008663 |
0.008635 |
466 |
REGULATION OF T HELPER 1 TYPE IMMUNE RESPONSE |
6 |
22 |
0.0008681 |
0.008635 |
467 |
POSITIVE REGULATION OF CELL SUBSTRATE ADHESION |
14 |
99 |
0.0008636 |
0.008635 |
468 |
AORTA MORPHOGENESIS |
6 |
22 |
0.0008681 |
0.008635 |
469 |
POSITIVE REGULATION OF MONOCYTE CHEMOTAXIS |
5 |
15 |
0.0008703 |
0.008635 |
470 |
CELLULAR RESPONSE TO INTERFERON GAMMA |
16 |
122 |
0.0008858 |
0.008769 |
471 |
INTERACTION WITH HOST |
17 |
134 |
0.0009078 |
0.008949 |
472 |
DNA REPLICATION |
23 |
208 |
0.0009063 |
0.008949 |
473 |
RENAL TUBULE DEVELOPMENT |
12 |
78 |
0.0009334 |
0.009183 |
474 |
SEGMENTATION |
13 |
89 |
0.0009599 |
0.009423 |
475 |
CELLULAR RESPONSE TO DNA DAMAGE STIMULUS |
59 |
720 |
0.0009649 |
0.009452 |
476 |
NEGATIVE REGULATION OF ENDOTHELIAL CELL MIGRATION |
8 |
39 |
0.0009751 |
0.009531 |
477 |
ADENYLATE CYCLASE INHIBITING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY |
11 |
68 |
0.0009839 |
0.009577 |
478 |
POSITIVE REGULATION OF INTERLEUKIN 6 PRODUCTION |
11 |
68 |
0.0009839 |
0.009577 |
479 |
NEGATIVE REGULATION OF NEURON APOPTOTIC PROCESS |
17 |
135 |
0.0009875 |
0.009593 |
480 |
REGULATION OF T CELL PROLIFERATION |
18 |
147 |
0.0009896 |
0.009593 |
481 |
REGULATION OF RESPONSE TO WOUNDING |
38 |
413 |
0.0009984 |
0.009658 |
482 |
RESPIRATORY SYSTEM DEVELOPMENT |
22 |
197 |
0.001018 |
0.009803 |
483 |
NEGATIVE REGULATION OF WNT SIGNALING PATHWAY |
22 |
197 |
0.001018 |
0.009803 |
484 |
APOPTOTIC SIGNALING PATHWAY |
29 |
289 |
0.001026 |
0.00986 |
485 |
NEGATIVE REGULATION OF CELL ADHESION |
24 |
223 |
0.001038 |
0.009962 |